MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Impact of non-pharmacological strategies on progression in Parkinson’s Disease and Cognitive Impairment.

    MAG. Medrano-Delgado, DR. Aguila-Godinez, MF. Ruiz-Mafud, LG. Lira-Juárez, EC. Santiago Delacruz, A. Domínguez-García, AJ. Hernández-Medrano, AY. Regalado-Mustafá, MF. Medina-Pérez, G. Hernandez-Armesto, K. Talavera-Laguna, A. Herrera-Ruiz, J. García-Hernández, DP. Romero-Terán, A. Alcocer-Salas, G. Cerda-Hernández, A. Abundes-Corona, M. Rodríguez-Violante, A. Cervantes-Arriaga (Ciudad de Mexico, Mexico)

    Objective: to determine the Impact of non-pharmacological strategies on progression in Parkinson's Disease and Cognitive Impairment. Background: PD is the second most common neurodegenerative disorder,…
  • 2023 International Congress

    Movement disorders at the National Institute of Neurology and Neurosurgery (INNN, Mexico City): most common diagnoses during 2022.

    D P. Romero Teran, A J. Hernández Medrano, D R. Aguila Godinez, A A. Herrera Ruiz, E C. Santiago Cruz, M. Medrano Delgado, M A. Ruiz Mafud, A Y. Regalado Mustafá, M F. Medina Perez, G I. Cerda Hernández, M. Rodriguez Violante, A. Cervantes Arriaga, G. Hernandez Armesto, A. Abundes Corona, A. Dominguez Garcia, K. Talavera Lagunas (CDMX, Mexico)

    Objective: To provide data about the movement disorders (MD) outpatient consultation (OC) service from the INNN, Mexico City during 2022. Background: The INNN, inaugurated in…
  • 2023 International Congress

    Correlation between dose of dopamine replacement therapy and King’s Parkinson’s Disease Pain Scale in Mexican Patients with Parkinson’s Disease

    A. Regalado Mustafá, D. Aguila Godinez, A. Herrera Ruiz, E. Santiago-de-La-Cruz, L. Lira Juárez, M. Medrano Delgado, M. Ruiz Mafud, A. Hernández-Medrano, D. Romero-Terán, M. Medina-Pérez, G. Cerda Hernández, M. Rodríguez-Violante, A. Cervantes-Arriaga, G. Hernandez Armesto, A. Abundes-Corona, A. Domínguez García, J. García Hernández, A. Alcocer Salas, K. Talavera Lagunas (Mexico City, Mexico)

    Objective: Investigate the relationship between the dose of dopamine replacement therapy (DRT) and pain severity as measured by the King's Parkinson's Disease Pain Scale (KPPS)…
  • 2023 International Congress

    Clinical toolkits to improve conversations about Parkinson’s dementia

    I. Dobreva, J. Thomas, M. Roche, C. Dore, S. Rose, S. Baldwin-Jones, R. O'Connell, A. Marr, C. Hugill, R. Weil (London, United Kingdom)

    Objective: To co-produce, with people living with Parkinson’s and professionals, a pair of toolkits to improve conversations about Parkinson’s dementia in the clinic: one for…
  • 2023 International Congress

    The phenotypic spectrum and assessment of severity in patients of Spinocerebellar Ataxia-12.

    V. Mathur, A. Shetty, P. Wadia (Jaipur, India)

    Objective: To describe clinical phenotype, manifestations, and assess tremor severity using standard rating scale in genetically confirmed patients with SCA12. Background: Spinocerebellar Ataxia-12 (SCA12) occurs…
  • 2023 International Congress

    Gender inequities in people living with PD and their caregivers’ burden in Mexican population

    AJ. Hernández-Medrano, DP. Romero-Terán, MA. Ruiz-Mafud, MAG. Medrano-Delgado, MF. Medina-Pérez, AY. Regalado-Mustafá, DR. Aguila-Godinez, LG. Lira-Juarez, A. Domínguez-García, G. Hernández-Armesto, EC. Santiago-Delacruz, AA. Herrera-Ruiz, K. Talavera Lagunas, GI. Cerda-Hernández, A. Alcocer-Salas, JF. García-Hernández, RA. Abundes-Corona, A. Cervantes-Arriaga, M. Rodríguez-Violante (La Fama, Tlalpan, Mexico)

    Objective: To compare motor and non-motor dysfunction, quality of life (QoL), and caregiver burden (CB) between women and men living with PD, and its relationship…
  • 2023 International Congress

    Natural history and disease progression biomarkers of multiple system atrophy: the ASPIRE-MSA study

    N. Del Campo, P. Péran, P. Payoux, V. Rousseau, A. Drif, H. Catalá, C. Thalamas, C. Tranchant, F. Duriff, A. Marques, JP. Azulay, C. Moreau, JC. Corvol, S. Thobois, AG. Corbille, S. Frismand, B. Patterson, A. Foubert-Samier, A. Pavy-Letraon, M. Fabbri, W. Meissner, O. Rascol (Toulouse, France)

    Objective: To evaluate multiple system atrophy (MSA) disease progression on a panel of candidate MSA biomarkers pre-selected for their putative involvement in the pathophysiology of…
  • 2023 International Congress

    Bilateral Globus Pallidus Internus Deep Brain Stimulation in Progressive Dystonia in Mohr-Tranebjaerg Syndrome: Case Report and Review

    L. Barcelos, M. Marinho, T. Capato, V. Borges, H. Ferraz (SAO PAULO, Brazil)

    Objective: We report a MTS patient genetically confirmed who presented with progressive generalized dystonia, deafness, and cognitive and behavioral abnormalities that were treated by internal…
  • 2023 International Congress

    The study of genetic factors in levodopa-induced motor complications development in Russian patients with Parkinson’s disease

    G. Akhmadeeva, I. Khidiyatova, I. Gilyazova, S. Umutbaev, R. Galimova, A. Baitimerov, R. Magzhanov (Ufa, Russian Federation)

    Objective: This study is aimed to explore the relationship between the single nucleotide polymorphisms (SNPs) in dopamine and serotonin metabolism genes, other neurotransmitter systems genes…
  • 2023 International Congress

    Expanding the reach of a telehealth psychotherapy hub to advance coordinated depression care for rural veterans with Parkinson’s Disease

    J. Mack, L. Marsh, A. Sarwar, K. Rodriguez, A. King, M. Hinojosa-Lindsey, R. Miller, L. ST. Hill, S. O'Connor, K. Ketchum, M. Latorre, A. Interian, R. Dobkin (Portland, USA)

    Objective: To describe the ongoing implementation and expansion of a telehealth psychotherapy hub to treat depression in rural Veterans with PD. Background: Depression is common…
  • « Previous Page
  • 1
  • …
  • 492
  • 493
  • 494
  • 495
  • 496
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley